RESEARCH TRIANGLE PARK, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company…
New data support Phase 3 development of Nyxol alone as a durable single eye drop for the potential treatment of…
Results show a strong first fiscal year, with $5.5 million in cash and continued growth from operationsVancouver, British Columbia--(Newsfile Corp.…
Vancouver, British Columbia--(Newsfile Corp. - January 31, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),…
Toronto, Ontario--(Newsfile Corp. - January 31, 2022) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it received a…
STOCKHOLM, SWEDEN / ACCESSWIRE / January 31, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)STOCKHOLM, 31 January 2022 - Promore Pharma announces today…
GENEVA, SWITZERLAND / ACCESSWIRE / January 31, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company…
While presented correctly in its Financial Statements and MD&A as filed on SEDAR, the date of the ending of Q2…
TORONTO, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF)…